Session I - Quest for a cure: have we lost the plot?
Session II - Spiralling costs: is rationing expensive cancer drugs the answer?
Session III - Cancer research: are we rewarding mediocrity while penalising real innovation?
Session IV - Personalised therapies: can tumour gene profiling live up to expectations?
